Literature DB >> 19697012

Magnesium modifies fentanyl-induced local antinociception and hyperalgesia.

Tufan Mert1, Yasemin Gunes, Dilek Ozcengiz, Ismail Gunay.   

Abstract

Fentanyl-induced hyperalgesia and antinociception after systemic administration has been shown in previous clinical and experimental studies. However, there is very little evidence regarding the local possible effects of fentanyl. The purpose of this study was to assess whether local (intraplantar) fentanyl administration can produce antinociception and hyperalgesia. In addition, we examined the effects of magnesium, N-methyl-D-aspartate receptor antagonist, on possible changes produced by fentanyl. The paw withdrawal latencies to radiant heat stimuli were measured to assess the thermal nociceptive actions. Intraplantar administration of fentanyl caused time and dose-dependent increase in the paw withdrawal latencies (antinociception). Coinjection of magnesium with fentanyl markedly enhanced the antinociception. However, fentanyl also markedly decreased paw withdrawal latencies 24 h after intraplantar administration (hyperalgesia). In the presence of magnesium, hyperalgesia after fentanyl administration was not observed. Consequently, following the fentanyl administration, local hyperalgesia after antinociception is a negative effect in pain treatment. Magnesium may not only prevent the hyperalgesia but also enhance antinociceptive effect of fentanyl.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697012     DOI: 10.1007/s00210-009-0447-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

Review 1.  Peripheral opioid analgesia.

Authors:  C Stein; H Machelska; W Binder; M Schäfer
Journal:  Curr Opin Pharmacol       Date:  2001-02       Impact factor: 5.547

Review 2.  Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy.

Authors:  Jianren Mao
Journal:  Pain       Date:  2002-12       Impact factor: 6.961

Review 3.  The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review.

Authors:  Andrei B Petrenko; Tomohiro Yamakura; Hiroshi Baba; Koki Shimoji
Journal:  Anesth Analg       Date:  2003-10       Impact factor: 5.108

Review 4.  Pharmacology of opioid and nonopioid analgesics in chronic pain states.

Authors:  T J Martin; J C Eisenach
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

5.  Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine.

Authors:  Cyril Rivat; Jean-Paul Laulin; Jean-Benoît Corcuff; Evelyne Célèrier; Laure Pain; Guy Simonnet
Journal:  Anesthesiology       Date:  2002-02       Impact factor: 7.892

6.  Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.

Authors:  S A Dunbar; I J Pulai
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

7.  Mu opioid receptors and analgesia at the site of a peripheral nerve injury.

Authors:  Wayne Truong; Chu Cheng; Qing-Gui Xu; Xia-Qing Li; Douglas W Zochodne
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

8.  Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats.

Authors:  Ilona Obara; Ryszard Przewlocki; Barbara Przewlocka
Journal:  Neurosci Lett       Date:  2004-04-22       Impact factor: 3.046

Review 9.  The induction of pain: an integrative review.

Authors:  M J Millan
Journal:  Prog Neurobiol       Date:  1999-01       Impact factor: 11.685

Review 10.  Mechanisms of opioid-induced tolerance and hyperalgesia.

Authors:  Anna DuPen; Danny Shen; Mary Ersek
Journal:  Pain Manag Nurs       Date:  2007-09       Impact factor: 1.929

View more
  4 in total

Review 1.  Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?

Authors:  D Andrew Tompkins; Claudia M Campbell
Journal:  Curr Pain Headache Rep       Date:  2011-04

2.  Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care.

Authors:  José Mario López-Saca; José Maria López-Picazo; Ana Larumbe; Juli Urdíroz; Carlos Centeno
Journal:  Support Care Cancer       Date:  2012-12-05       Impact factor: 3.603

3.  A comparison of intrathecal magnesium and ketamine in attenuating remifentanil-induced hyperalgesia in rats.

Authors:  Jiehao Sun; Hai Lin; Xiaona Feng; Jiaojiao Dong; Emmanuel Ansong; Xuzhong Xu
Journal:  BMC Anesthesiol       Date:  2016-09-06       Impact factor: 2.217

4.  Magnesium sulphate attenuate remifentanil-induced postoperative hyperalgesia via regulating tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord.

Authors:  Jiehao Sun; Hai Lin; Guodong He; Wendong Lin; Jianping Yang
Journal:  BMC Anesthesiol       Date:  2017-02-21       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.